PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.29
Similar ESG score to RNAZ's 63.21. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
50.00
Environmental score 90-95% of RNAZ's 55.41. Bill Ackman would demand clear environmental improvement catalysts.
62.54
Social score 90-95% of RNAZ's 67.22. Bill Ackman would demand clear social improvement catalysts.
68.32
Similar governance score to RNAZ's 67.01. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.